"I agree strongly with CMP. The sp reflects DE1 only. There is nothing else that is part of the company that is being counted and that's including the 50 million plus in cash we have."

I'm not following you guys on this point. How can the share price not reflect, in some amount, speculative value for DE2 (and DE 3 and beyond)? In fact, it must also reflect some speculative value for a commercial amount of tonnage represented by DE1, 2, 3 et al. Plus, does anyone of us actually know what DE1 is worth, by itself?

If the hypothesis (sp reflects DE1 only) were true, wouldn't that mean that if DE2 assay results were, by the estimation of posters on this board, poor, that the share price wouldn't fall? I'm all for that, but I don't believe the sp wouldn't be hit significantly if DE2 disappointed.

There is something that the share-price-determining public (traders, new long term investors and existing long term investors willing to part with some or all of their shares) expects from the anticipated assays. What that is, I certainly don't know. But I'm confident that if the assays are better than the collective expectations, the sp will rise, and if worse, it will fall.